Literature DB >> 27295613

Host factors associated with serologic inflammatory markers assessed using multiplex assays.

Heather S McKay1, Jay H Bream2, Joseph B Margolick2, Otoniel Martínez-Maza3, John P Phair4, Charles R Rinaldo5, Alison G Abraham6, Lisa P Jacobson6.   

Abstract

Chronic systemic inflammation contributes to the development of adverse health conditions, yet the influence of fixed and modifiable risk factors on many serologic biomarkers of inflammation remains largely unknown. Serum concentrations of twenty-three biomarkers, including C-reactive protein (CRP), cytokines (CXCL11, CXCL8, CXCL10, CCL2, CCL13, CCL4, CCL17, CXCL13, IL-10, IL-12p70, IL-6, TNF-α, IL-2, IFN-γ, IL-1β, GM-CSF, BAFF), and soluble immune receptors (sCD14, sIL-2Rα, sCD27, sgp130, sTNF-R2) were measured longitudinally using multiplexed immunometric assays in 250 HIV-uninfected men followed in the Multicenter AIDS Cohort Study (1984-2009). Generalized gamma regression was used to determine the statistical significance of factors associated with each biomarker. After accounting for age, race, and education, and for analysis of multiple biomarkers, higher concentrations of specific individual biomarkers were significantly (P<0.002) associated with hypertension, obesity, hepatitis C infection, stimulant use, and diabetes and lower concentrations with hypercholesterolemia. These associations should be taken into account in epidemiological studies of these biomarkers, and may provide potential targets for disease prevention and treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Chemokines; Cytokine receptors; Cytokines; Immune activation; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 27295613      PMCID: PMC5088708          DOI: 10.1016/j.cyto.2016.05.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  78 in total

Review 1.  Pancreatic cancer, inflammation, and microbiome.

Authors:  Constantinos P Zambirinis; Smruti Pushalkar; Deepak Saxena; George Miller
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

2.  Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications.

Authors:  M M Doody; M S Linet; A G Glass; R E Curtis; L M Pottern; B B Rush; J D Boice; J F Fraumeni; G D Friedman
Journal:  Epidemiology       Date:  1996-03       Impact factor: 4.822

Review 3.  The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Authors:  M Zeremski; L M Petrovic; A H Talal
Journal:  J Viral Hepat       Date:  2007-10       Impact factor: 3.728

Review 4.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

5.  Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.

Authors:  Paul Welsh; Mark Woodward; Ann Rumley; Gordon Lowe
Journal:  Br J Haematol       Date:  2008-03-26       Impact factor: 6.998

Review 6.  HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.

Authors:  Giuseppe Castello; Stefania Scala; Giuseppe Palmieri; Steven A Curley; Francesco Izzo
Journal:  Clin Immunol       Date:  2009-11-11       Impact factor: 3.969

7.  Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.

Authors:  Christoph Garbers; Wolfgang Thaiss; Gareth W Jones; Georg H Waetzig; Inken Lorenzen; Florence Guilhot; Rami Lissilaa; Walter G Ferlin; Joachim Grötzinger; Simon A Jones; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

8.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

9.  Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.

Authors:  Brian M Nolen; Elizabeth Crabb Breen; Jay H Bream; Frank J Jenkins; Lawrence A Kingsley; Charles R Rinaldo; Anna E Lokshin
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

10.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.

Authors:  D D Taub; A R Lloyd; K Conlon; J M Wang; J R Ortaldo; A Harada; K Matsushima; D J Kelvin; J J Oppenheim
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  8 in total

1.  Inflammation and Risk of Depression in HIV: Prospective Findings From the Multicenter AIDS Cohort Study.

Authors:  Haidong Lu; Pamela J Surkan; Michael R Irwin; Glenn J Treisman; Elizabeth C Breen; Ned Sacktor; Ron Stall; Steven M Wolinsky; Lisa P Jacobson; Alison G Abraham
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

2.  Biomarkers of cavernous angioma with symptomatic hemorrhage.

Authors:  Seán B Lyne; Romuald Girard; Janne Koskimäki; Hussein A Zeineddine; Dongdong Zhang; Ying Cao; Yan Li; Agnieszka Stadnik; Thomas Moore; Rhonda Lightle; Changbin Shi; Robert Shenkar; Julián Carrión-Penagos; Sean P Polster; Sharbel Romanos; Amy Akers; Miguel Lopez-Ramirez; Kevin J Whitehead; Mark L Kahn; Mark H Ginsberg; Douglas A Marchuk; Issam A Awad
Journal:  JCI Insight       Date:  2019-06-20

3.  Host characteristics associated with serologic inflammatory biomarkers in women.

Authors:  Sophia S Wang; Charlie Zhong; Marta Epeldegui; Sarah Nunes; Larry Magpantay; Jessica Clague DeHart; Susan Hurley; Debbie Goldberg; Elena Martinez; James V Lacey; Otoniel Martinez-Maza; Peggy Reynolds
Journal:  Cytokine       Date:  2021-10-16       Impact factor: 3.861

4.  Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

Authors:  Jeffrey E Teigler; Louise Leyre; Nicolas Chomont; Bonnie Slike; Ningbo Jian; Michael A Eller; Nittaya Phanuphak; Eugène Kroon; Suteeraporn Pinyakorn; Leigh Anne Eller; Merlin L Robb; Jintanat Ananworanich; Nelson L Michael; Hendrik Streeck; Shelly J Krebs
Journal:  JCI Insight       Date:  2018-05-17

5.  Effect of Statin Use on Inflammation and Immune Activation Biomarkers in HIV-Infected Persons on Effective Antiretroviral Therapy.

Authors:  Shehnaz K Hussain; Asieh Golozar; Daniel P Widney; Giovanna Rappocciolo; Sudhir Penugonda; Jay H Bream; Otoniel Martínez-Maza; Lisa P Jacobson
Journal:  AIDS Res Hum Retroviruses       Date:  2020-12-29       Impact factor: 1.723

6.  Metabolic endotoxaemia related inflammation is associated with hypogonadism in overweight men.

Authors:  Kelton Tremellen; Natalie McPhee; Karma Pearce
Journal:  Basic Clin Androl       Date:  2017-03-08

7.  Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.

Authors:  Tania S Bonny; Eshan U Patel; Xianming Zhu; Evan M Bloch; M Kate Grabowski; Alison G Abraham; Kirsten Littlefield; Ruchee Shrestha; Sarah E Benner; Oliver Laeyendecker; Shmuel Shoham; David Sullivan; Thomas C Quinn; Arturo Casadevall; Andrew Pekosz; Andrew D Redd; Aaron A R Tobian
Journal:  Open Forum Infect Dis       Date:  2020-11-26       Impact factor: 3.835

8.  Data on serologic inflammatory biomarkers assessed using multiplex assays and host characteristics in the Multicenter AIDS Cohort Study (MACS).

Authors:  Heather S McKay; Jay H Bream; Joseph B Margolick; Otoniel Martínez-Maza; Larry I Magpantay; John P Phair; Charles R Rinaldo; Alison G Abraham; Lisa P Jacobson
Journal:  Data Brief       Date:  2016-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.